Abstract:Tumuröse Läsionen oder tumorähnliche Läsionen peripherer Nerven sind insgesamt selten, heterogen und herausfordernd in Diagnose und Therapie. Sie können durch tastbare Schwellungen in Nähe zu Nerven, sensible und/oder motorische Defizite, Berührungsschmerz oder neuropathischen Schmerz auffällig werden. In 91% der Fälle sind Tumore gutartig. Vor diesem Hintergrund sind eine Differenzierung der Entitäten, ihrer Charakteristika und eine funktionserhaltene Resektionsstrategie hochgradig relevant. Fehldiagnosen können gravierende Effekte für die Patienten mit schweren neurologischen Schäden und Schmerzsyndromen haben. Gutartige Tumore sind Schwannome und Neurofibrome, die sporadisch auftreten können aber auch bei Häufung mit neurogenetischen Tumordispositionssyndromen vergesellschaftet sein können. Seltenere gutartige Nerventumore sind Perineuriome, Lipome, die aggressive Fibrose (Desmoidtumor), Paragangliome und Hämangiome. Als tumorähnliche Läsionen werden die Ganglienzyste beschrieben. Die Assoziation von Nerventumoren zu neurogenetischen Syndromen und eine richtige Zuordnung von möglicherweise malignen Läsionen, wie dem MPNST (Maligne Periphere Nervenscheidentumor) oder den Zwischenstufen wie z. B. den ANNUBPs (atypische neurofibromatöse Neoplasien mit unbekanntem biologischem Potential) stellen besondere Herausforderungen dar. Die Interdisziplinarität hat eine hohe Relevanz für die klinische Behandlung und korrekte Diagnosestellung. Das Ziel unserer Arbeit ist die Übersicht über die relevanten Entitäten, die Diagnostik und zeitgemäße Therapiestrategien anhand der aktuellen Datenlage und unter Berücksichtigung der kürzlich erschienen interdisziplinären AWMF S2K-Leitlinie "Diagnostik und Therapie peripherer Nerventumore". Tumorous or tumour-like lesions of peripheral nerves are generally rare, heterogeneous and challenging to diagnose and treat. They may become apparent by a palpable swelling (lump) near nerves, sensory and/or motor deficits, pain to touch or neuropathic pain. In 91% of cases, tumours are benign. The differentiation of entities and their characteristics as well as a function-preserving resection strategy are highly relevant. Misdiagnosis and inadequate treatment can lead to severe deficits and pain syndromes. Benign tumours include schwannomas and neurofibromas, which can occur sporadically but can also be associated with neurogenetic tumour disposition syndromes if they occur more frequently. Rarer benign nerve tumours include perineuriomas, lipomas, aggressive fibrosis (desmoid tumours), paragangliomas and haemangiomas. Ganglion cysts are described as tumour-like lesions. The association of nerve tumours with neurogenetic syndromes and the correct classification of potentially malignant lesions such as MPNST (malignant peripheral nerve sheath tumour) or intermediate stages such as ANNUBPs (atypical neurofibromatous neoplasms with unknown biological potential) pose particular challenges. Interdisciplinarity is highly relevant for clinical treatment and a correct diagnosis. The aim of our work is to provide an overview of the relevant entities, diagnostic evaluation and contemporary treatment strategies based on the current data situation and taking into account the recently published interdisciplinary AWMF S2k guideline "Diagnosis and Treatment of Peripheral Nerve Tumours". Received: 27 November 2023 Accepted: 21 December 2023 Article published online: 20 March 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Practical Approach to Histological Diagnosis of Peripheral Nerve Sheath Tumors: An Update

Path-25. Consensus Recommendations For An Integrated Diagnostic Approach To Nerve Sheath Tumors Arising In The Setting Of Neurofibromatosis Type 1

Collection of Rare Peripheral Nerve Tumors-Insights from the German Registry

An algorithmic approach to the management of peripheral nerve tumours

Image-Based Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

Peripheral Nerve Sheath Tumors of Head and Neck: Imaging-Based Review of World Health Organization Classification.

The Multimodality Management of Malignant Peripheral Nerve Sheath Tumours

A series of 146 peripheral non-neural sheath nerve tumors: 30-year experience at Louisiana State University Health Sciences Center

Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

Neurofibromatosis to neoplasia transition: a rare case report of spindle cell malignant peripheral nerve sheath tumor with literature review

From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor

Interdisziplinäre Behandlung von Raumforderungen in Assoziation zu peripheren Nerven: Tumore und tumorähnliche Läsionen

Clinical Characteristics and Management Experience of Schwannoma in Extremities: Lessons Learned from a 10-Year Retrospective Study

Surgical Treatment and Targeted Therapy for a Large Metastatic Malignant Peripheral Nerve Sheath Tumor: A Case Report and Literature Review

Perioperative Observations and Outcome in Surgical Treatment of Malignant Peripheral Nerve Sheath Tumors

Schwannomatosis: a New Member of Neurofibromatosis Family.

Diagnosis and treatment of the schwannomatosis

Accidental diagnosis of a giant malignant peripheral nerve sheath tumor associated with neurofibromatosis type 1 in the back area: a case report

Spatial gene expression profiling unveils immuno-oncogenic programs of NF1-associated peripheral nerve sheath tumor progression

Malignant tumor of the peripheral nerve sheaths in the parotid gland - a case report

Outcomes of Treatment for Malignant Peripheral Nerve Sheath Tumors: Different Clinical Features Associated with Neurofibromatosis Type 1